PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential

PD-1/PD-L1 immune checkpoint inhibitors show potential for cervical cancer treatment. However, low response rates suggest that patient selection based on PD-L1 protein expression is not optimal. Here, we evaluated different PD-L1 detection methods and studied transcriptional regulation of PD-L1/PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotman, Jossie, den Otter, Leontine A. S., Bleeker, Maaike C. G., Samuels, Sanne S., Heeren, A. Marijne, Roemer, Margaretha G. M., Kenter, Gemma G., Zijlmans, Henry J. M. A. A., van Trommel, Nienke E., de Gruijl, Tanja D., Jordanova, Ekaterina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793653/
https://www.ncbi.nlm.nih.gov/pubmed/33424844
http://dx.doi.org/10.3389/fimmu.2020.596825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793653/
https://www.ncbi.nlm.nih.gov/pubmed/33424844
http://dx.doi.org/10.3389/fimmu.2020.596825

Ejemplares similares